Allurion Technologies (ALURD) Change in Accured Expenses (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Change in Accured Expenses came in at -$1.4 million in Q1 2026, up 7.15% YoY from -$1.3 million in Q1 2025, and up 30.39% on a QoQ basis from -$2.0 million in Q4 2025.
Allurion Technologies (ALURD) Change in Accured Expenses (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 7.15% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 million (down 8.52% YoY) and the FY2025 annual result came in at -$5.0 million, down 23.86% from the prior year.
- Change in Accured Expenses improved to -$1.4 million in Q1 2026, from -$2.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.7 million in Q4 2024 to a low of -$6.1 million in Q3 2024.
- A 5-year average of -$222333.3 and a median of -$724000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 196.91% in 2024, down 453.17% in 2024.
- Tracing ALURD's Change in Accured Expenses over 5 years: stood at $2.5 million in 2022, then slumped by 254.05% to -$3.8 million in 2023, then surged by 196.91% to $3.7 million in 2024, then sank by 152.86% to -$2.0 million in 2025, then soared by 30.39% to -$1.4 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.4 million (Q1 2026), -$2.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.36 Mn |
| Mar 31, 2026 | -1.36 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | -6.06 Mn |
| Sep 30, 2024 | -6.06 Mn |
| Jun 30, 2024 | -724,000.00 |
| Jun 30, 2024 | -724,000.00 |
| Mar 31, 2024 | -989,000.00 |
| Mar 31, 2024 | -989,000.00 |
| Dec 31, 2023 | -3.82 Mn |
| Dec 31, 2023 | -3.82 Mn |